• Yun-Hao Xun, Jian-Chun Guo, Guo-Qiang Lou, Yan-Ming Jiang, Zhen-Jie Zhuang, Meng-Fei Zhu, Yan Luo, Xiao-Jie Ma, Jing Liu, Dong-Xue Bian, and Jun-Ping Shi.
• Department of Liver Diseases, Xixi Hospital of Hangzhou, Hangzhou, Zhejiang, China.
• Clin. Exp. Pharmacol. Physiol. 2014 Sep 1; 41 (9): 643-9.

AbstractThe non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS) has emerged as a useful predictor of long-term outcome in NAFLD patients. We evaluated the predictive performance of the NFS for overall mortality in a Chinese population with NAFLD. All NAFLD patients diagnosed ultrasonographically at Xixi Hospital of Hangzhou between 1996 and 2011 were retrospectively recruited to the study. Outcome was determined by interview and causes of death were confirmed by medical records. The area under the receiver operating characteristic curve (AUCROC ) was used to determine the predictive accuracy of the NFS, BARD (body mass index, aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio, diabetes) score, FIB-4 index and the AST/platelet ratio index (APRI) for mortality. Data from a total of 180 eligible patients (median age 39 years; 96 men) were analysed, with 12 deaths over a median follow-up period of 6.6 years (range 0.5-14.8 years). Using Cox model analysis, the NFS as a continuous variable was identified as the only predictor for all-cause mortality (hazard ratio 2.743, 95% confidence interval (CI) 1.670-4.504). The NFS yielded the highest AUCROC of 0.828 (95% CI 0.728-0.928, P < 0.05), followed by the FIB-4 index, APRI and BARD score (AUCROC 0.806 (P < 0.05), 0.732 (P < 0.05) and 0.632, respectively). The data indicated that the NFS is a useful predictor of 6.6-year all-cause mortality for Chinese patients with NAFLD. © 2014 Wiley Publishing Asia Pty Ltd.

27 keywords...

hide…